Pharmacy actuarial experts discuss the potential implications of the recent Rx Executive Order and Tariffs on various groups of stakeholders in the United States pharmacy eco-system.
- Future Actuaries
-
Education & Exams
Educational Pathways Associate of the Society of Actuaries (ASA) Fellow of the Society of Actuaries (FSA) Chartered Enterprise Risk Analyst (CERA) Micro-Credentials
- Professional Development
-
Research Institute
Aging & Retirement Artificial Intelligence Catastrophe and Climate COVID-19 Disability Diversity Equity & Inclusion Finance & Investment General Insurance Global Health Care Cost Trends Innovation & Technology Life & Annuities Long-Term Care Mortality & Longevity Predictive Analytics & Modeling Risk Management U.S. Population Valuation/IllustrationsSponsorships Proposal Requests Data Requests Calls for Papers Funding & Grants Competitions & Awards Academic & Student Research
- Communities
- Tools & Resources
-
About SOA
Topics in the News
- Future Actuaries
-
Education & Exams
- Professional Development
-
Research Institute
-
Aging & Retirement Artificial Intelligence Catastrophe and Climate COVID-19 Disability Diversity Equity & Inclusion Finance & Investment General Insurance Global Health Care Cost Trends Innovation & Technology Life & Annuities Long-Term Care Mortality & Longevity Predictive Analytics & Modeling Risk Management U.S. Population Valuation/Illustrations
-
- Communities
-
Tools & Resources
-
About SOA
-
Topics in the News
Back to Top